The European Commission granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union

Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent...

Related Keywords

Milan ,Lombardia ,Italy ,Switzerland ,Austria ,Texas ,United States ,United Kingdom ,Houston ,Vienna ,Wien ,America ,Micaela Colamasi ,Christian Herold ,Max Wintermark ,Fulvio Renoldi Bracco ,Committee For Medicinal Products Human Use ,European Committee ,Department Of Biomedical Imaging ,Bracco Group ,Department Of Neuroradiology ,European Medicines Agency ,European Union ,University Of Texas Md Anderson Cancer Center ,Drug Administration ,Nuclear Medicine ,European Commission ,University Of Vienna ,Medicinal Products ,Human Use ,Marketing Authorisation ,Full Professor ,Biomedical Imaging ,Image Guided Therapy ,Medical University ,Vienna General Hospital ,Cancer Center ,Central Nervous System ,Magnetic Resonance Imaging ,Full Text View ,Body Magnetic Resonance Imaging ,Bracco Imaging ,Contrast Enhanced Ultrasound ,Invest Radiol ,Half Dose Gadopiclenol ,Full Dose Gadobutrol ,Contrast Enhanced Body ,Novel Drug Approvals ,